Abstract:Changes to the immune system after stroke are complex and can result in both pro-inflammatory and immunosuppressive consequences. Following ischemic stroke, brain resident microglia are activated and circulating monocytes are recruited to the injury site. In contrast, there is a systemic deactivation of monocytes/macrophages that may contribute to immunosuppression and the high incidence of bacterial infection experienced by stroke patients. The manipulation of macrophage subsets may be a useful therapeutic strategy to reduce infection and improve outcome in patients after stroke. Recent research has enhanced our understanding of the heterogeneity of macrophages even within the same tissue. The spleen is the largest natural reservoir of immune cells, many of which are mobilized to the site of injury after ischemic stroke and is notable for the diversity of its functionally distinct macrophage subpopulations associated with specific micro-anatomical locations. Here, we describe the effects of experimental stroke in mice on these distinct splenic macrophage subpopulations. Red pulp (RP) and marginal zone macrophages (MZM) specifically showed increases in density and alterations in micro-anatomical location. These changes were not due to increased recruitment from the bone marrow but may be associated with increases in local proliferation. Genes associated with phagocytosis and proteolytic processing were upregulated in the spleen after stroke with increased expression of the lysosome-associated protein lysosomal-associated membrane proteins specifically increased in RP and MZM subsets. In contrast, MHC class II expression was reduced specifically in these populations. Furthermore, genes associated with macrophage ability to communicate with other immune cells, such as co-stimulatory molecules and inflammatory cytokine production, were also downregulated in the spleen after stroke. These findings suggest that selective splenic macrophage functions could be impaired after stroke and the contribution of macrophages to stroke-associated pathology and infectious complications should be considered at a subset-specific level. Therefore, optimal therapeutic manipulation of macrophages to improve stroke outcome is likely to require selective targeting of functionally and spatially distinct subpopulations.

Quantitative and Correlational Analysis of Brain and Spleen Immune Cellular Responses Following Cerebral Ischemia

Systemic immune responses after ischemic stroke: From the center to the periphery

Immunoreactive Cells after Cerebral Ischemia

63. Immune Response in Acute Ischaemic Stroke

Targeting Brain-spleen Crosstalk After Stroke: New Insights Into Stroke Pathology and Treatment

Diurnal Differences in Immune Response in Brain, Blood and Spleen After Focal Cerebral Ischemia in Mice

Novel Subsets of Peripheral Immune Cells Associated with Promoting Stroke Recovery in Mice.

Sustained Increases in Immune Transcripts and Immune Cell Trafficking During the Recovery of Experimental Brain Ischemia.

Post-ischemic inflammatory response in the brain: Targeting immune cell in ischemic stroke therapy

Experimental Stroke Differentially Affects Discrete Subpopulations of Splenic Macrophages

Systematic Study of the Immune Components after Ischemic Stroke Using CyTOF Techniques

Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke

The “Dialogue” Between Central and Peripheral Immunity After Ischemic Stroke: Focus on Spleen

Perspective Review of Myeloid Immune Cell Responses and Poststroke Immunosuppression

Molecular Dialogs Between the Ischemic Brain and the Peripheral Immune System: Dualistic Roles in Injury and Repair.

Macrophage and monocyte subsets in response to ischemic stroke

Research progress on immune-related therapeutic targets of brain injury caused by cerebral ischemia

Identification of Circulating Immune Landscape in Ischemic Stroke based on Bioinformatics Methods

Roles of Peripheral Immune Cells in the Recovery of Neurological Function after Ischemic Stroke

Analysis of brain and blood single-cell transcriptomics in acute and subacute phases after experimental stroke

The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke